NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/09/2019
Back to search
Official data from USPTO
GENEVIEVE PROTOCOL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GENEVIEVE PROTOCOL
ST13
US500000077389950Class
44
Filing
77389950
Registration
3661647
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
09/09/2019
Trademark type
Word
Nice classes
44
Filing date
02/06/2008
Registration date
07/28/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/09/2019
Last transaction
09/09/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/04/2009
First use in commerce
02/04/2009
Drawing code
4
Owner type
03
Owner location
SAN MARINO, CA
Examiner
CHUO, EMILY M
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
GENVIVO, INC.
E. C. (pessoa física)
Representatives
Jean L. Batman Legal Venture Counsel, Inc.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical services featuring a clinical protocol wherein two distinct tumor-targeted gene vectorsone carrying a cytocidal gene (a mutated cyclin G1)the other bearing an immunomodulatory cytokine gene (GM-CSF)are used in combination for cancer immunotherapy or cancer vaccination
Publications
History of USPTO decisions and trademark events.
39 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/09/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/09/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/06/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
07/27/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/30/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/28/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/09/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/09/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/08/2014
E815
TEAS SECTION 8 & 15 RECEIVED
11/17/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
07/28/2009
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
06/23/2009
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/17/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/05/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/31/2009
GNRT
NON-FINAL ACTION E-MAILED
03/31/2009
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/31/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/31/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/31/2009
IUAF
USE AMENDMENT FILED
03/09/2009
EISU
TEAS STATEMENT OF USE RECEIVED
03/09/2009
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/20/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
09/30/2008
PUBO
PUBLISHED FOR OPPOSITION
07/08/2008
NPUB
NOTICE OF PUBLICATION
06/18/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/02/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/30/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/29/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/29/2008
ALIE
ASSIGNED TO LIE
05/20/2008
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/20/2008
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/20/2008
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
05/20/2008
DOCK
ASSIGNED TO EXAMINER
05/16/2008
NWAP
NEW APPLICATION ENTERED
02/12/2008
Continuous trademark protection
Get notified about every new filing that threatens GENEVIEVE PROTOCOL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.